Security record · archived quarter
GERN
Geron Corporation · Healthcare · Biotechnology
9Tracked holders
0Δ holders
71.98MShares held
$326.79MReported value
+2New positions
−2Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +7.3% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | +1 | 281.21M | $360.08M | +7 | −8 |
| Q1 2026 | 93 | -3 | 271.64M | $404.62M | +7 | −10 |
| Q4 2025 | 95 | -3 | 246.07M | $324.82M | n/a | −3 |
| Q3 2025 | 17 | 0 | 193.54M | $265.15M | +2 | −2 |
| Q2 2025 | 14 | +1 | 162.89M | $229.67M | +1 | n/a |
| Q1 2025 | 10 | -1 | 76.28M | $121.30M | n/a | −1 |
| Q4 2024 | 11 | +1 | 96.17M | $340.44M | +2 | −1 |
| Q3 2024 | 9 | 0 | 71.98M | $326.79M | +2 | −2 |
| Q2 2024 | 9 | n/a | 67.08M | $284.41M | n/a | n/a |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 12.66M | +4.7% | $57.49M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | T. Rowe Price ✦ | 7.04M | -37.6% | $31.95M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 3 | D. E. Shaw & Co. ✦ | 31.99K | New | $145,239 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| D. E. Shaw & Co. | $145,239 | 0.0% |
Exited
| Renaissance Technologies | $3.31M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 253 holders, 492.17M shares, $730.64M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Aug 14
SC 13G/A: RA CAPITAL MANAGEMENT, L.P.
Aug 07
SC 13G: STATE STREET CORP
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API